Redhill Biopharma reported $-13238000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Cara Therapeutics CARA:US $ -4472000 23.44M
Cronos Group Inc CRON:CN -28066000 19.22M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
Redhill Biopharma RDHL:US $ -13.24M 7.46M